Effect of milrinone on short-term outcome of patients with myocardial dysfunction undergoing coronary artery bypass graft: A randomized controlled trial

Cardiology Journal

Volumn 17, Issue 1, 2010, Pages 73-78

  Jebeli, Mohammad ^a   Ghazinoor, Mohammad ^b   Mandegar, Mohammad Hussein ^a   Rasouli, Mohammad R ^a   Eghtesadi Araghi, Payam ^a   Goodarzynejad, Hamidreza ^c   Mohammadzadeh, Robabeh ^a   Darehzereshki, Ali ^a   Dianat, Saied ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Left ventricular dysfunction; Low left ventricular ejection fraction; Low output syndrome; Milrinone; On pump coronary artery bypass graft

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; INOTROPIC AGENT; MILRINONE; PLACEBO;

ADULT; AGED; AORTA BALLOON; ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATINE KINASE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FORWARD HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FAILURE; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MORTALITY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; CREATINE KINASE; CREATINE KINASE, MB FORM; DRUG ADMINISTRATION SCHEDULE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INCIDENCE; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MILRINONE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PERIOPERATIVE CARE; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 75749090783     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Heringlake M, Wernerus M, Grunefeld J et al. The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting. Crit Care, 2007; 11: R51.
2. Jeon Y, Ryu JH, Lim YJ et al. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients. Eur J Cardiothorac Surg, 2006; 29: 952-956.
3. Avery GJ 2nd, Ley SJ, Hill JD, Hershon JJ, Dick SE. Cardiac surgery in the octogenarian: Evaluation of risk, cost, and outcome. Ann Thorac Surg, 2001; 71: 591-596.
4. Liu LL, Gropper MA. Respiratory and hemodynamic management after cardiac surgery. Curr Treat Options Cardiovasc Med, 2002; 4: 161-169.
5. Bristow MR, Hershberger RE, Port JD et al. Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation, 1990; 82: I12-I25.
6. Bristow MR, Ginsburg R, Minobe W et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med, 1982; 307: 205-211.
7. Schwinn DA, Leone BJ, Spahn DR et al. Desensitization of myocardial beta-adrenergic receptors during cardiopulmonary bypass. Evidence for early uncoupling and late downregulation. Circulation, 1991; 84: 2559-2567.
8. Benotti JR, Grossman W, Braunwald E, Davolos DD, Alousi AA. Hemodynamic assessment of amrinone. A new inotropic agent. N Engl J Med, 1978; 299: 1373-1377.
9. Baim DS, McDowell AV, Cherniles J et al. Evaluation of a new bipyridine inotropic agent, milrinone, in patients with severe congestive heart failure. N Engl J Med, 1983; 309: 748-756.
10. Kikura M, Levy JH, Michelsen LG et al. The effect of milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass. Anesth Analg, 1997; 85: 16-22.
11. Kikura M, Levy JH, Bailey JM, Shanewise JS, Michelsen LG, Sadel SM. A bolus dose of 1.5 mg/kg amrinone effectively improves low cardiac output state following separation from cardiopulmonary bypass in cardiac surgical patients. Acta Anaesthesiol Scand, 1998; 42: 825-833.
12. Rathmell JP, Prielipp RC, Butterworth JF et al. A multicenter, randomized, blind comparison of amrinone with milrinone after elective cardiac surgery. Anesth Analg, 1998; 86: 683-690.
13. Lutter G, Saurbier B, Nitzsche E et al. Transmyocardial laser revascularization (TMLR) in patients with unstable angina and low ejection fraction. Eur J Cardiothorac Surg, 1998; 13: 21-26.
14. Sedlis SP, Ramanathan KB, Morrison DA, Sethi G, Sacks J, Henderson W. Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry). Am J Cardiol, 2004; 49: 118-120.
15. Muller M, Junger A, Brau M et al. Incidence and risk calculation of inotropic support in patients undergoing cardiac surgery with cardiopulmonary bypass using an automated anaesthesia record--keeping system. Br J Anaesth, 2002; 89: 398-404.
16. Bailey JM, Levy JH, Kikura M, Szlam F, Hug CC Jr. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. Anesthesiology, 1994; 81: 616-622.
17. Mollhoff T, Schmidt C, Van Aken H et al. Myocardial ischaemia in patients with impaired left ventricular function undergoing coronary artery bypass grafting - milrinone versus nifedipin. Eur J Anaesthesiol, 2002; 19: 796-802.
18. Feneck RO. Effects of variable dose milrinone in patients with low cardiac output after cardiac surgery. European Multicenter Trial Group. Am Heart J, 1991; 121: 1995-1999.
19. Wright EM, Sherry KM. Clinical and haemodynamic effects of milrinone in the treatment of low cardiac output after cardiac surgery. Br J Anaesth, 1991; 67: 585-590.
20. Hein M, Roehl AB, Baumert JH, Scherer K, Steendijk P, Rossaint R. Anti-ischemic effects of inotropic agents in experimental right ventricular infarction. Acta Anaesthesiol Scand, 2009; 53: 941-948.
21. Sanada S, Kitakaze M, Papst PJ et al. Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: The role of protein kinase A and p38 mitogen-activated protein kinase. Circulation, 2001; 104: 705-710.
22. Levy JH, Bailey JM, Deeb GM. Intravenous milrinone in cardiac surgery. Ann Thorac Surg, 2002; 73: 325-330.
23. Konstam MA, Cody RJ. Short-term use of intravenous milrinone for heart failure. Am J Cardiol, 1995; 75: 822-826.
24. George M, Lehot JJ, Estanove S. Haemodynamic and biological effects of intravenous milrinone in patients with a low cardiac output syndrome following cardiac surgery: multicentre study. Eur J Anaesthesiol, 1992; 5: 31-34.